Commentary to "The Possible Role of Nutraceuticals in the Prevention of Cardiovascular Disease"
- 1 June 2019
- journal article
- editorial
- Published by Springer Nature in High Blood Pressure & Cardiovascular Prevention
- Vol. 26 (3) , 259-261
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Efficacy of omega-3 polyunsaturated fatty acids supplementation in managing overweight and obesity: A meta-analysis of randomized clinical trialsThe Journal of nutrition, health and aging, 2017
- Joint position statement on “Nutraceuticals for the treatment of hypercholesterolemia” of the Italian Society of Diabetology (SID) and of the Italian Society for the Study of Arteriosclerosis (SISA)Nutrition, Metabolism and Cardiovascular Diseases, 2017
- 2016 ESC/EAS Guidelines for the Management of DyslipidaemiasEuropean Heart Journal, 2016
- The effects of a nutraceutical combination on plasma lipids and glucose: A systematic review and meta -analysis of randomized controlled trialsPharmacological Research, 2016
- Effects of a nutraceutical combination on lipids, inflammation and endothelial integrity in patients with subclinical inflammation: a randomized clinical trialScientific Reports, 2016
- Nutraceuticals: Definition and Epidemiological Rationale for Their Use in Clinical PracticeHigh Blood Pressure & Cardiovascular Prevention, 2015
- Cardiovascular Prevention: The Role of Second Generation of NutraceuticalsHigh Blood Pressure & Cardiovascular Prevention, 2015
- Nutraceuticals for the treatment of hypercholesterolemiaEuropean Journal of Internal Medicine, 2014
- The treatment of hypercholesterolemic children: Efficacy and safety of a combination of red yeast rice extract and policosanolsNutrition, Metabolism and Cardiovascular Diseases, 2011
- Attenuation of inflammation with short-term dietary intervention is associated with a reduction of arterial stiffness in subjects with hypercholesterolaemiaEuropean Journal of Preventive Cardiology, 2004